Our blog includes news from LINQ, information about recent events in the projects we work with, and insights into the markets and funding programmes relevant to our projects.
The fourth annual meeting of the PredictTB project was held on October 13-14, 2021. The virtual meeting aimed to take stock of the project’s progress over the last year and make plans for the final nine months.
On October 5-6, 2021, IMPRINT held its third and final network meeting. The virtual meeting looked back on the network's progress and impact since its inception in 2017 and offered IMPRINT members the opportunity to meet and exchange thoughts and knowledge relating to maternal immunisation.
On October 14, the WHO published its Global Tuberculosis Report 2021. The report shows how TB milestones and targets have been hit hard by the COVID-19 pandemic.
Core-NB studies the impact of TB and HIV on COVID-19 outcomes
We are delighted to announce that we have just added a new project to the LINQ portfolio, Core-NB, coordinated by Prof Stefan Niemann of Research Center Borstel, Germany.
iMAP: The vision of a world free from heart attacks and stroke
LINQ has been supporting the Cambridge-led iMAP consortium in the planning and preparation of the iMAP proposal. The group of world-leading scientists are set out to make atherosclerosis a disease of the past.
Long-awaited first Horizon Europe HEALTH calls are now open
The first Horizon Europe HEALTH calls for proposals were launched on June 22. At LINQ, we are now rolling up our sleeves and getting ready to support research proposals initiated by our longstanding partners as well as new clients.
The EUCANCan consortium held its annual meeting on May 20-21. The goal of the meeting was to take stock of the project’s progress to date and discuss upcoming milestones.
The EDCTP and AIGHD launched a global Tuberculosis (TB) vaccine research and development roadmap at the Virtual Global Forum on TB Vaccines on April 20, 2021.
